Search results
Senators blame sky-high drug prices on abuse of the patent system
NBC NEWS· 6 days agoThe patent system is meant to reward innovation by allowing drugmakers to exclusively sell new...
Cipla receives final approval for the generic version of Somatuline® Depot (Lanreotide) Injection...
FOX 5 San Diego· 5 days agoCipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline® Depot (Lanreotide) Injection.
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Zacks· 14 hours agoFree Report) is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. Shares of this Zacks Rank #3 (Hold) company have risen ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 4 days agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
Patent reform could be the next big move to help bring down drug prices
Axios· 5 days agoWhy it matters: There's widespread agreement that pharmaceutical companies have gamed the system...
The #1 Mistake People Make While on Weight Loss Drugs Like Ozempic, According to an Obesity Doctor
Parade via Yahoo News· 6 days agoWegovy, a drug made by the same company as Ozempic but is approved for weight loss, has also...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 7 days agoActavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. Forest...
Online Pharmacy Launches Cheaper Version of Ozempic
Futurism via Yahoo News· 4 days agoThe company behind those viral erectile dysfunction ads is releasing its own version of Ozempic — but its means of acquiring the drug might not be the...
The #1 Mistake People Make While on Weight Loss Drugs Like Ozempic, According to an Obesity Doctor
Parade· 6 days agoPrescriptions for Ozempic—a drug used to manage type 2 diabetes and that many also take for weight...
Pay for Delay Is Sometimes Okay | JD Supra
JD Supra· 3 days agoThe US Court of Appeals for the Second Circuit affirmed the dismissal of a lawsuit against pharmaceutical companies accused of violating antitrust laws by using reverse payments to delay entry ...